|
|
 |
| OVERVIEW |
| |
|
NYC Bioscience Bulletin provides the latest news and information on the thriving bioscience cluster in New York City. This month's issue features several major funding agreements and the recognition of NYC's expanding healthcare system.
Visit www.nycbiotech.org or contact us for more information on how New York City Economic Development Corporation can assist your business. |
|
| IN THE NEWS |
| |
|
Record-Breaking Expansion for NYC's Healthcare System
The New York Sun recently reported on the expansion of New York City's healthcare industry. The article highlights a $242 million Heart Center at Columbia Presbyterian Hospital, Weill Cornell Medical Center's $650 million Biomedical Research Building, and a proposal by St. Vincent's Hospital to construct an $800 million “green” hospital. Also mentioned is the $700 million East River Science Park. |
| Top ^ |
 |
|
Antigenics to Raise $26 Million in Private Placement
Antigenics Inc., a New York City based biotechnology company working to develop treatments for cancers and infectious diseases, announced that it will receive $26.1 million in a private placement. Antigenics also recently announced positive data resulting from a Phase I vaccine study. |
| Top ^ |
|
|
Lev Pharmaceuticals Announces $20 Million Funding
New York City based Lev Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of inflammatory diseases, received $20 million to finance additional plasma purchases. This financing is in addition to its recent $35 million offering and a $21 million private placement raised in 2006. |
| Top ^ |
|
|
IAVI Receives $900,000 for AIDS Vaccine Research
The International AIDS Vaccine Initiative (IAVI), a global not-for-profit organization whose mission is to ensure the development of HIV vaccines for use throughout the world, announced that BD, a global medical technology company, will provide the non-profit organization with $900,000 in cash, equipment and medical supplies over the next three years. BD's support will provide critical technologies for IAVI's laboratories in the U.S., Europe, India and Africa. |
| Top ^ |
|
|
NYCEDC to Host Biotech R&D Funding Conference
NYCEDC, in conjunction with Industrial and Technology Assistance Corporation (ITAC), will host a Biotech R&D Funding Conference at Columbia University's Lerner Hall in Manhattan on March 18. The event will highlight R&D funding opportunities for bioscience companies, including NIH SBIR and QETC. In addition to expert speakers and panels, this event will feature one-on-one meetings with NIH Federal program managers. Special thanks to Columbia Science and Technology Ventures and our supporter Fish & Richardson, P.C. An agenda and registration will be available soon through www.nycedc.com/bioscience. |
| Top ^ |
|
|
Stem Cell Summit Coming to New York City
The Third Annual Stem Cell Summit will be held on February 26th and will showcase investment opportunities in the stem cell marketplace, groundbreaking stem cell products, and more. The NYC Bioscience Initiative will be present at this event that will feature over 50 presenters, four panels of experts, as well as a reception and networking opportunities. For more information visit www.stemcellsummit.com. |
| Top ^ | |
|